Free Trial

COSCIENS Biopharma (CSCI) Stock Chart & Stock Price History

$2.94 -0.06 (-2.00%)
As of 03:51 PM Eastern

COSCIENS Biopharma Stock Price Performance

5 Day
Performance
+1.73%
1 Month
Performance
+17.60%
3 Month
Performance
-20.54%
Year-To-Date
Performance
+6.14%
Receive CSCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for COSCIENS Biopharma and its competitors with MarketBeat's FREE daily newsletter.

CSCI Stock Chart for Tuesday, January, 21, 2025

COSCIENS Biopharma Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
01/21/2025$3.00$2.94
-2.00%
$3.13$2.8012,610 shs$11.05 million
01/20/2025$3.00$3.00$3.13$2.895,445 shs$11.28 million
01/17/2025$2.89$3.00
+3.81%
$3.13$2.895,445 shs$11.28 million
01/16/2025$2.97$2.89
-2.69%
$3.06$2.758,834 shs$10.87 million
01/15/2025$3.22$2.97
-7.76%
$3.15$2.774,872 shs$11.16 million
01/14/2025$3.18$3.22
+1.26%
$3.23$3.03679 shs$12.10 million
01/13/2025$3.40$3.18
-6.47%
$3.41$3.183,598 shs$11.95 million
01/10/2025$3.22$3.40
+5.59%
$3.41$3.225,131 shs$12.78 million
01/09/2025$3.22$3.22$3.51$3.224,981 shs$12.10 million
01/08/2025$3.43$3.22
-6.12%
$3.51$3.224,981 shs$12.10 million
01/07/2025$3.63$3.43
-5.51%
$3.60$3.354,729 shs$12.89 million
01/06/2025$3.36$3.63
+8.04%
$3.71$3.3715,846 shs$13.65 million
01/03/2025$2.73$3.36
+23.08%
$3.48$2.8077,368 shs$10.26 million
01/02/2025$2.77$2.73
-1.44%
$2.88$2.734,511 shs$10.26 million
01/01/2025$2.77$2.77$2.90$2.688,589 shs$10.41 million
12/31/2024$2.84$2.77
-2.46%
$2.90$2.688,589 shs$10.41 million
12/30/2024$2.67$2.84
+6.37%
$2.91$2.5612,546 shs$10.68 million
12/27/2024$2.79$2.67
-4.30%
$2.68$2.653,937 shs$10.04 million
12/26/2024$2.67$2.79
+4.49%
$2.79$2.672,831 shs$10.49 million
12/25/2024$2.67$2.67$2.67$2.551,781 shs$10.04 million
12/24/2024$2.59$2.67
+3.09%
$2.67$2.551,781 shs$10.04 million
12/23/2024$2.50$2.59
+3.60%
$2.78$2.5010,245 shs$9.74 million
12/20/2024$2.79$2.50
-10.39%
$2.74$2.505,466 shs$9.40 million


This page (NASDAQ:CSCI) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners